ARA-290 10mg / Cibinetide

ARA-290 10 mg — S.T.A.R. Laboratories

A research peptide studied for nerve repair, inflammation, and tissue protection.

ARA-290, also known as cibinetide, is a synthetic 11-amino-acid peptide developed from a portion of erythropoietin (EPO). It is designed to activate the innate repair receptor, a signalling pathway involved in tissue protection and repair, without stimulating red blood cell production like conventional EPO. (pmc.ncbi.nlm.nih.gov)

Potential benefits being investigated include:

• Nerve regeneration: Researchers are examining its effects on small nerve fibres, with early clinical studies reporting improvements in certain markers of nerve fibre regeneration.
• Inflammation modulation: Preclinical studies explore its potential to reduce inflammatory signalling associated with nerve injury.
• Cellular and tissue protection: Research investigates how ARA-290 influences protective responses to tissue stress and damage. (pmc.ncbi.nlm.nih.gov, pubmed.ncbi.nlm.nih.gov)

Early findings are promising, particularly in research involving sarcoidosis-associated small-fibre neuropathy. However, these studies do not establish ARA-290 as a proven treatment for nerve damage, chronic pain, or general recovery. Long-term safety and effectiveness remain uncertain. (pmc.ncbi.nlm.nih.gov, pubmed.ncbi.nlm.nih.gov)

Product details

• Compound: ARA-290 / Cibinetide
• Vial content: 10 mg
• Form: Lyophilized powder
• Intended use: Laboratory research only

For research purposes only. Not for human consumption or administration. This product is not intended to diagnose, treat, cure, or prevent any disease.